This site is intended for healthcare professionals only
LoginRegister
Quadria Capital sells entire stake in Akums for Rs 311 croreAkums Drugs, Zambia Govt Ink USD 50 Mn Medicine Supply Deal, Pharma Plant by 2028
USFDA Announces Major Push to Speed Biosimilar Development, Slash Biologic Drug CostsUSFDA Suspends Ixchiq Chikungunya Vaccine License Citing Encephalitis Death, 20+ Serious Adverse...
Aurobindo Pharmas subsidiary CuraTeQ Biologics Secures MHRA Approval for Trastuzumab Biosimilar Dazublys in HER2-Positive CancerAurobindo Pharma's subsidiary CuraTeQ Biologics Secures MHRA Approval for Trastuzumab Biosimilar...
Royalty PharmaRoyalty Pharma to Buy USD 950 Million Royalty Stake in Amgen's Small Cell Lung Cancer Drug Imdelltra
Sun Pharma Asked to Resubmit Revised Phase III Protocol for Delafloxacin CABP TrialSun Pharma Wins CDSCO Panel Approval for Phase III Vitiligo Trial of Ruxolitinib Cream
Chhattisgarh Pharma Firm Slapped Recall Notice Over Defective Paracetamol TabletsChhattisgarh Pharma Firm Slapped Recall Notice Over Defective Paracetamol Tablets
Delhi pharma firm owner caught in drug trafficking case in JammuCrime Branch Busts Illegal Psychotropic Drug Trade, Pharmacist Among 3 Held
CDSCO Panel Directs Mankind Pharma to Conduct Phase I Trial of Sintilimab Before Phase III LaunchDelhi HC Cancels UNKIND Trademark, Upholds Mankind Pharma's KIND Family Rights
82% government hospitals in Rajasthan still without Biometric Attendance systemOnly 13% of 95,000 Approved Faculty Onboarded: PCI Gives 15-Day Deadline for Biometric Attendance in...
Discharge Paper Withheld: Consumer Court Directs Hospital to Pay Rs 60 K FineVLCC Slapped Rs 3 Lakh Fine Over Misleading CoolSculpting Weight-Loss Ads
Eris Lifesciences Secures CDSCO Panel Nod to Conduct BE Study on Dapagliflozin, Pioglitazone, Metformin FDCEris Lifesciences receives ANVISA approval at its Ahmedabad campus
No More Offline Filings: CDSCO Mandates Submission of Post-Approval Changes for Cell and Gene Therapy Trial via SUGAM PortalCDSCO Panel Asks Unique Biotech to Submit Approval Status of Bacillus coagulans Unique IS-2 2...
X